PCSA · Processa Pharmaceuticals, Inc. · Off Exchange
$1.97
-0.02 (-1.01%)
At close · Sep 10
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.56M
Shares
2.79M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-08-03 | 46,109 | 174,835 | 220,944 | 44.0% |
| 2026-07-27 | 165,807 | 5,646,608 | 5,812,415 | 49.9% |
| 2026-07-20 | 31,502 | 268,577 | 300,079 | 61.6% |
| 2026-07-13 | 10,423 | 185,575 | 195,998 | 70.1% |
| 2026-07-06 | 16,167 | 182,878 | 199,045 | 62.8% |
| 2026-06-29 | 19,893 | 192,658 | 212,551 | 61.5% |
| 2026-06-22 | 4,641 | 122,741 | 127,382 | 63.3% |
| 2026-06-15 | 7,780 | 96,817 | 104,597 | 56.7% |
| 2026-06-08 | 37,258 | 291,490 | 328,748 | 62.2% |
| 2026-06-01 | 21,910 | 178,786 | 200,696 | 61.8% |
| 2026-05-25 | 5,780 | 137,424 | 143,204 | 66.6% |
| 2026-05-18 | 11,071 | 203,015 | 214,086 | 72.1% |
| 2026-05-11 | 23,830 | 304,502 | 328,332 | 61.7% |
| 2026-05-04 | 2,800 | 62,443 | 65,243 | 62.5% |
| 2026-04-27 | 8,644 | 98,116 | 106,760 | 68.1% |
| 2026-04-20 | 14,301 | 254,146 | 268,447 | 60.8% |
| 2026-04-13 | 14,997 | 246,573 | 261,570 | 73.4% |
| 2026-04-06 | 16,283 | 205,651 | 221,934 | 47.0% |
| 2026-03-30 | 14,808 | 195,480 | 210,288 | 60.2% |
| 2026-03-23 | 6,227 | 49,977 | 56,204 | 58.8% |
| 2026-03-16 | 13,762 | 169,952 | 183,714 | 60.4% |
| 2026-03-09 | 9,305 | 74,092 | 83,397 | 62.3% |
| 2026-03-02 | 10,044 | 158,274 | 168,318 | 67.4% |
| 2026-02-23 | 7,976 | 82,896 | 90,872 | 55.1% |
| 2026-02-16 | 2,840 | 53,866 | 56,706 | 60.1% |
| 2026-02-09 | 11,276 | 122,107 | 133,383 | 65.6% |
| 2026-02-02 | 34,136 | 208,868 | 243,004 | 51.2% |
| 2026-01-26 | 4,928 | 73,422 | 78,350 | 56.2% |
| 2026-01-19 | 15,152 | 170,788 | 185,940 | 59.3% |
| 2026-01-12 | 50,745 | 286,057 | 336,802 | 66.6% |
| 2026-01-05 | 33,182 | 419,489 | 452,671 | 72.9% |
| 2025-12-29 | 33,686 | 399,934 | 433,620 | 62.2% |
| 2025-12-22 | 97,114 | 706,389 | 803,503 | 60.6% |
| 2025-12-15 | 81,112 | 1,354,279 | 1,435,391 | 3.3% |
| 2025-12-08 | 18,844 | 86,965 | 105,809 | 100.0% |
| 2025-12-01 | 8,039 | 98,586 | 106,625 | 100.0% |
| 2025-11-24 | 6,060 | 100,329 | 106,389 | 100.0% |
| 2025-11-17 | 9,710 | 177,321 | 187,031 | 100.0% |
| 2025-11-10 | 17,101 | 199,076 | 216,177 | 100.0% |
| 2025-11-03 | 23,324 | 432,160 | 455,484 | 100.0% |
| 2025-10-27 | 41,287 | 1,228,941 | 1,270,228 | 100.0% |
| 2025-10-20 | 59,591 | 522,990 | 582,581 | 100.0% |
| 2025-10-13 | 47,640 | 961,869 | 1,009,509 | 100.0% |
| 2025-10-06 | 206,580 | 9,161,072 | 9,367,652 | 100.0% |
| 2025-09-29 | 2,141 | 233,299 | 235,440 | 100.0% |
| 2025-09-22 | 4,392 | 530,015 | 534,407 | 100.0% |
| 2025-09-15 | 4,416 | 279,635 | 284,051 | 100.0% |
Showing 1–47 of 47 weeks
Key facts
CIK
1533743
CUSIP
74275C403
13F (30d)
12 filings
12 filers
Visit website
Investor relations